Cargando…
Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans
Hepatocellular death contributes to progression of alcohol–associated (ALD-associated) and non–alcohol-associated (NAFL/NASH) liver diseases. However, receptor-interaction protein kinase 3 (RIP3), an intermediate in necroptotic cell death, contributes to injury in murine models of ALD but not NAFL/N...
Autores principales: | Miyata, Tatsunori, Wu, Xiaoqin, Fan, Xiude, Huang, Emily, Sanz-Garcia, Carlos, Ross, Christina K. Cajigas-Du, Roychowdhury, Sanjoy, Bellar, Annette, McMullen, Megan R., Dasarathy, Jaividhya, Allende, Daniela S., Caballeria, Joan, Sancho-Bru, Pau, McClain, Craig J., Mitchell, Mack, McCullough, Arthur J., Radaeva, Svetlana, Barton, Bruce, Szabo, Gyongyi, Dasarathy, Srinivasan, Nagy, Laura E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934930/ https://www.ncbi.nlm.nih.gov/pubmed/33616081 http://dx.doi.org/10.1172/jci.insight.140180 |
Ejemplares similares
-
Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans
por: Miyata, Tatsunori, et al.
Publicado: (2022) -
Macrophage‐derived MLKL in alcohol‐associated liver disease: Regulation of phagocytosis
por: Wu, Xiaoqin, et al.
Publicado: (2023) -
Dysregulated meta-organismal metabolism of aromatic amino acids in alcohol-associated liver disease
por: Mrdjen, Marko, et al.
Publicado: (2023) -
A novel score of IL-13 and age predicts 90-day mortality in severe alcohol-associated hepatitis: A multicenter plasma biomarker analysis
por: Tornai, David, et al.
Publicado: (2023) -
Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease
por: Sandlers, Yana, et al.
Publicado: (2020)